Print Page  |  Contact Us  |  Report Abuse  |  Sign In  |  Join ACAM
News & Press: The Link Newsletter

The Link Newsletter: October 2016 Issue

Wednesday, October 5, 2016   (0 Comments)
Posted by: Administration
Share |
Does Big Ag really feed the world? New data says not so much.
READ MORE

The 'well from hell' - my fight with BP to film Deepwater Horizon
READ MORE

What's at stake for the climate in the 2016 election? Everything.
READ MORE

Phthalates in fast food: A potential dietary source of exposure
Toxins linger in homes long after smokers quit
READ MORE

Toward a better beauty regimen: Reducing potential EDC exposures from personal care products
READ MORE

Brain diseases manifest in the retina of the eye
READ MORE

Abnormal brain protein may contribute to Alzheimer's disease development
READ MORE

Air pollution could be to blame for hundreds of traffic accidents, warn researchers.
READ MORE

Dr. Henry Childers is board certified in General Surgery, and Cardiothoracic Surgery, with advanced certificates in both FSM and ozone therapy. He is a fellow in the American Academy of Ozone Therapy and is co-investigator on the Health and Human Services Institutional Review Board Ozone efficacy research study.
 
Dr. Childers has a special interest in alternative therapies for the treatment of Lyme Disease and is one of the only Lyme Literate medical doctors (LLMD) in the region.

Dr. Childers received his medical degree from Tufts University School of Medicine, completed his surgery residency at the New York Hospital-Cornell Medical Center and a fellowship in cardiothoracic surgery at the University of Pennsylvania. He was a senior clinical associate in surgery at Cornell University Medical College and served as chief resident in the Department of Surgery at The New York Hospital-Cornell Medical Center. He has also practiced cardiothoracic surgery at the University of Pennsylvania Division of Cadiothoracic Surgery. LEARN MORE
SPONSORED ADVERTISEMENT

ADVANCED NUTRITIONAL

SUPPLEMENTS & SUPERFOODS

Health Products Distributors, Inc. (HPDI)

supplies practitioners with a complete line of high-quality nutritional supplements and superfoods. ACAM members apply for a reseller account today! LEARN MORE!

BRIGHT FOLIAGE, AUTUMN HARVEST, AND COZY FIRES
Autumn has always been my very favorite time of the year. That first nip in the air, the smell of roasting chilies almost everywhere you go, the bountiful harvest of cool weather crops, the smell of burning pinion and cedar and the spectacular oranges, browns and golds of the fading cottonwood trees make one pause to take in all of its glory. Yes, the days are getting shorter, but fear not, our easily available vitamin D3, is just a reach away at your favorite store and it is your main hedge against a multitude of winter's ailments from depression  to the flu. If you're either curious or concerned about a health issue, ask you primary care provider to test your level. Primary care docs like to use the D2 form, but why take something that needs to be converted to the more bio available form when the preferred product is so handy. If your doc insists you get a vitamin D2 prescription, tell him or her that you won't need any refills because you plan to buy it over the counter and start taking it every day.
 READ MORE

CHICKEN FLORENTINE
INGREDIENTS:
Chicken fillets, 2 small packages
Fresh spinach leaves, one large container
2 medium green or yellow squash

Click HERE for entire recipe!


Submitted by Nutrasal and Dr. K.J. Gundermann
NAFLD is probably the most common liver disorder in the world with a prevalence rate ranging from 6% to 35% of the general population, and a median rate of 20%.  There is strong evidence that the occurrence of NAFLD is likely to correspond to regional trends in over nutrition, obesity, type 2 diabetes and metabolic syndrome.  The disorder equally affects both sexes. Although, it is most common in overweight and obese persons and in patients with adult onset (type 2) diabetes, it can also be present in lean persons and in overweight children and adolescents.

NAFLD represents a spectrum of hepatic disorders characterized by macrovesicular fatty liver, with histology ranging from steatosis to non-alcoholic steatohepatitis (NASH), to NAFLD-associated cirrhosis and to hepatic cancer. It is the risk of progression from fatty liver as a benign disorder to liver disease with inflammation, fibrogenesis and cell death that makes NAFLD a medical challenge, as an established therapy is not yet available.
A decade of clinical trials did not reveal a single intervention that has convincingly improved all important outcomes for all NAFLD patients. Low-calorie diet and physical exercise are accepted as a basic universal approach, but considering the rate at which NAFLD is becoming a worldwide epidemic, new therapeutic concepts are needed. LEARN MORE
IN SIMILIAR NEWS: Women at higher risk for alcoholic liver disease than men READ MORE
SPONSORED ADVERTISEMENT

ANH ACTION ALERT!
 
FRANKENBROCOLLI FOR DINNER
Organic products are at risk. 

ANH ACTION ALERT! 
EPA SCIENTISTS ARE NOT DUMB
Their political and industry bosses must have told them what to say. 
  ANH ACTION ALERT! 
FDA TRIES TO RUN OUT CLOCK ON BILL TO HELP DYING PATIENTS
New federal legislation offers dying patients new hope. It needs our support.  


Community Search
Sign In


Forgot your password?

Haven't registered yet?

Calendar

9/14/2017 » 9/17/2017
ACAM 2017 Annual Meeting

Latest News
Online Surveys